Fig. 7
Selected de novo generated candidates, synthesis routes based on in-house building blocks, and their experimentally validated activity. A–C Selected candidates 1, 2, 3 for experimental evaluation and their respective in-house synthesis routes. D) Residual MGLL enzyme activity after treatment with varying concentrations of inhibitor as measured by natural substrate assay (compare Supplementary: Experimental Evaluation D for details)